Moens, S., Zhao, P., Baietti, M. F., Marinelli, O., Haver, D. V., Impens, F., . . . Amant, F. (2021). The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers. Nature Portfolio.
Style de citation Chicago (17e éd.)Moens, Stijn, et al. The Mitotic Checkpoint Is a Targetable Vulnerability of Carboplatin-resistant Triple Negative Breast Cancers. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Moens, Stijn, et al. The Mitotic Checkpoint Is a Targetable Vulnerability of Carboplatin-resistant Triple Negative Breast Cancers. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.